Compare Godaddy Inc (GDDY) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs Globus Medical Inc. Class A Common Stock — how do they compare? Godaddy Inc trades at $103.55 (market cap $13.09B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: Godaddy Inc is the larger of the two by market cap, and Godaddy Inc is more actively traded (1,383,795 versus 1,059,528). Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 65 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| GDDY | GMED | |
|---|---|---|
Market Cap | $13.09B | $10.25B |
Volume | 1,383,795 | 1,059,528 |
Sector | Technology | Health |
52-Week High | $135.18 | $96.82 |
52-Week Low | $75.07 | $58.33 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | $15.78B | $9.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $103.03, up 0.69% with a bullish technical signal. The company shows strong fundamentals with consistent earnings beats, 17.83% net income margin, and robust cash flow generation. Recent quarterly results exceeded expectations, with Q2 2026 EPS of $1.83 beating the $1.69 estimate. However, the stock faces headwinds from multiple securities class action lawsuits alleging misrepresentations about domain contract terms.
Despite legal challenges, GoDaddy maintains solid operational performance with improving revenue trends and strong profitability metrics. Analyst consensus remains positive with 55% buy ratings, though the $96 consensus price target suggests limited upside. Key risks include litigation outcomes and competitive pressures in the domain services market.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
